Search filters

List of works by Rebecca Kristeleit

Phase I trial of the poly(ADP-ribose) polymerase (PARP) inhibitor olaparib and AKT inhibitor capivasertib in patients with BRCA1/2 and non-BRCA1/2 mutant cancers

scientific article published on 12 June 2020

Paulina is supported by:

About Paulina

Help